Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 4Phase 3 3Phase NA 2Phase 1/2 2Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Breast Neoplasms 13Lymphoma, Large B-Cell, Diffuse 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasm, Residual 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Burkitt Lymphoma 3Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Leukemia 2Hodgkin Disease 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Rhabdomyosarcoma 1Recurrence 1Obesity 1Neoplasms, Plasma Cell 1Neoplasms 1Medulloblastoma 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1

Interventions

Thalidomide 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Immunoglobulin Light-chain Amyloidosis × Cyclophosphamide × Clear all
NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Guangdong Provincial People's Hospital

Phase 4 Unknown
70 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡